Sign in

CIK 0001357459

  • Non-accelerated filer
  • Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522007292
Phone
+1 858-704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
  1. 4 Open-market buy Chief Executive Officer bought 35,715 shares at $0.28 ($10,000)
  2. 4 Open-market buy Chief Executive Officer bought 35,715 shares at $0.28 ($10,000)
  3. 4 Open-market buy Chief Financial Officer bought 31,250 shares at $0.32 ($10,000)
  4. 4 Open-market buy Chief Executive Officer bought 31,250 shares at $0.32 ($10,000)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes CEO gave up 6,465 shares (to pay taxes)
  8. 4 Option exercise Director acquired 15,000 shares (option exercise)
  9. 4 Shares withheld for taxes CEO gave up 37,776 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 39,178 shares (to pay taxes)
  11. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.09 ($27,250)
  12. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.18 ($29,500)
  13. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.17 ($29,355)
  14. 4 Gift CEO gave 66,953 shares (gift)
  15. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.13 ($28,190)
  16. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.23 ($30,690)
  17. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.31 ($32,725)
  18. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.26 ($31,460)
  19. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.64 ($41,000)
  20. 4 Gift CEO gave 100,000 shares (gift)

Page 10 of 18 · 343 filings